Bank of Montreal’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Bank of Montreal’s Portfolio NBSE Stock Details NBSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-23	Closed	-$3K	–	5126
2021 Q1	$3K	Sell	23 -106	-82%	-$19.2K	﹤0.01%	4858
2020 Q4	$20K	Buy	129 +90	+231%	+$14.6K	﹤0.01%	4425
2020 Q3	$6K	Sell	39 -30	-43%	-$4.89K	﹤0.01%	4373
2020 Q2	$11K	Buy	+69	New	+$11.5K	﹤0.01%	4142
2016 Q4	–	Sell	-6	Closed	-$7K	–	4225
2016 Q3	$7K	Sell	6 -7	-54%	-$7.55K	﹤0.01%	3653
2016 Q2	$14K	Hold	13	–	–	﹤0.01%	3497
2016 Q1	$16K	Hold	13	–	–	﹤0.01%	3478
2015 Q4	$31K	Hold	13	–	–	﹤0.01%	3225
2015 Q3	$14K	Hold	13	–	–	﹤0.01%	3385
2015 Q2	$13K	Hold	13	–	–	﹤0.01%	3414
2015 Q1	$13K	Buy	+13	New	+$42.9K	﹤0.01%	3420

Other funds holding NBSE

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

JAMONY

Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return

PCM

Prelude Capital Management New York $1.31B AUM 62.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of Montreal's NBSE Position: Q2 2021 in Review

Bank of Montreal sold out of NeuBase Therapeutics, Inc. Common Stock (NBSE) in Q2 2021, closing a stake of 23 shares — an estimated $3K sold.

Bank of Montreal first reported a position in NBSE in Q1 2015 and held it in 11 quarters. The position peaked at $31K in Q4 2015. 57 funds tracked by Wall St. Rank hold NBSE as of Q2 2021.

Bank of Montreal reported no remaining NeuBase Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Bank of Montreal sold 23 NeuBase Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $3K.
Bank of Montreal first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q1 2015 and held it in 11 quarters.
Bank of Montreal's NeuBase Therapeutics, Inc. Common Stock position peaked at $31K in Q4 2015.
57 funds tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.